Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo
Open Access
- 24 May 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 107 (1), 63-70
- https://doi.org/10.1038/bjc.2012.188
Abstract
The small stress heat shock protein 27 (Hsp27) has recently turned as a promising target for cancer treatment. Hsp27 upregulation is associated with tumour growth and resistance to chemo- and radio-therapeutic treatments, and several ongoing drugs inhibiting Hsp27 expression are under clinical trial. Hsp27 is now well described to counteract apoptosis and its elevated expression is associated with increased aggressiveness of several primary tumours. However, its role in the later stage of tumour progression and, more specifically, in the later and most deadly stage of tumour metastasis is still unclear. In the present study, we showed by qRT–PCR that Hsp27 gene is overexpressed in a large fraction of the metastatic breast cancer area in 53 patients. We further analysed the role of this protein in mice during bone metastasis invasion and establishment by using Hsp27 genetically depleted MDA-MB231/B02 human breast cancer cell line as a model. We demonstrate that Hsp27 silencing led to reduced cell migration and invasion in vitro and that in vivo it correlated with a decreased ability of breast cancer cells to metastasise and grow in the skeleton. Altogether, these data characterised Hsp27 as a potent therapeutic target in breast cancer bone metastasis and skeletal tumour growth.Keywords
This publication has 41 references indexed in Scilit:
- Knock Down of Heat Shock Protein 27 (HspB1) Induces Degradation of Several Putative Client ProteinsPLOS ONE, 2012
- Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κBBreast Cancer Research, 2011
- Guidelines for the welfare and use of animals in cancer researchBritish Journal of Cancer, 2010
- Substrate binding site flexibility of the small heat shock protein molecular chaperonesProceedings of the National Academy of Sciences of the United States of America, 2009
- Heat Shock Protein 27 Protects L929 Cells from Cisplatin-Induced Apoptosis by Enhancing Akt Activation and Abating Suppression of Thioredoxin Reductase ActivityClinical Cancer Research, 2007
- Hsp27 (HspB1) and αB‐crystallin (HspB5) as therapeutic targetsFEBS Letters, 2007
- Heat shock protects cardiac cells from doxorubicin-induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27American Journal of Physiology-Heart and Circulatory Physiology, 2006
- Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissuesZeitschrift für Krebsforschung und Klinische Onkologie, 2005
- Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genesLaboratory Investigation, 2005
- Low Cell Motility Induced by hsp27 Overexpression Decreases Osteolytic Bone Metastases of Human Breast Cancer Cells In VivoJournal of Bone and Mineral Research, 1999